These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A comparison between single and double-pump syringe changes of intravenous inotropic medications in children. Powell ML; Carnevale FA Dynamics; 2004; 15(4):10-4. PubMed ID: 15638352 [TBL] [Abstract][Full Text] [Related]
43. Determining i.v. infusion rates for critical care drugs using a microcomputer. Oszko MA Hosp Pharm; 1989 Jun; 24(6):465-6, 483. PubMed ID: 10318282 [TBL] [Abstract][Full Text] [Related]
44. Intraosseous infusion: a re-discovered procedure as an alternative for pediatric vascular access. Jaimovich DG; Kecskes S Indian J Pediatr; 1991; 58(3):329-34. PubMed ID: 1937643 [TBL] [Abstract][Full Text] [Related]
46. The influence of age on drug metabolism. Implications for drug dosage. Triggs EJ; Hooper WD; Dickinson RG Med J Aust; 1984 Dec 8-22; 141(12-13):823-7. PubMed ID: 6390104 [No Abstract] [Full Text] [Related]
48. High-technology in home care. An overview of intravenous therapy. Sheldon P; Bender M Nurs Clin North Am; 1994 Sep; 29(3):507-19. PubMed ID: 8090645 [TBL] [Abstract][Full Text] [Related]
49. New England Deaconess guidelines for the administration of i.v. drugs. Sesin P; Wiggins MS NITA; 1987; 10(3):224-34. PubMed ID: 3648519 [No Abstract] [Full Text] [Related]
50. Blocking i.v. drug incompatibilities. Trissel LA Nursing; 1993 Jun; 23(6):74. PubMed ID: 8510845 [No Abstract] [Full Text] [Related]
52. Standard drug concentrations and smart-pump technology reduce continuous-medication-infusion errors in pediatric patients. Larsen GY; Parker HB; Cash J; O'Connell M; Grant MC Pediatrics; 2005 Jul; 116(1):e21-5. PubMed ID: 15995017 [TBL] [Abstract][Full Text] [Related]
53. Issues and problems associated with drug delivery in pediatric patients. Roberts RJ J Clin Pharmacol; 1994 Jul; 34(7):723-4. PubMed ID: 7929866 [TBL] [Abstract][Full Text] [Related]
54. New England Deaconess guidelines for the administration of i.v. drugs. Sesin P; Wiggins MS NITA; 1987; 10(2):129-38. PubMed ID: 3645343 [No Abstract] [Full Text] [Related]
57. Implementation of intelligent infusion technology in a multihospital setting. Dusing Wiest M; Longshore L; Harger N Am J Health Syst Pharm; 2010 Jun; 67(11):878-83. PubMed ID: 20484209 [No Abstract] [Full Text] [Related]
58. [Pharmacokinetic methods for achieving and maintaining stationary plasma levels in the venous administration of drugs]. Iamboliev I; Genov D Khirurgiia (Sofiia); 1990; 43(5):46-53. PubMed ID: 2102938 [TBL] [Abstract][Full Text] [Related]
59. Effect of infusion pump fill-stroke flow interruptions on simulated serum concentrations of short half-life drugs. Floyd RA Am J Hosp Pharm; 1984 Nov; 41(11):2399-400. PubMed ID: 6507446 [No Abstract] [Full Text] [Related]
60. Development and implementation of a pediatric/neonatal i.v. syringe pump delivery system. McCurdy DE; Arnold MT Neonatal Netw; 1995 Apr; 14(3):9-18. PubMed ID: 7603426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]